Literature DB >> 20384600

Brain functional changes (QEEG cordance) and worsening suicidal ideation and mood symptoms during antidepressant treatment.

A M Hunter1, A F Leuchter, I A Cook, M Abrams.   

Abstract

OBJECTIVE: Antidepressant medications are efficacious overall; however, some individuals experience worsening mood symptoms and increased suicidal ideation (SI) during treatment. We examined the quantitative electroencephalographic (QEEG) cordance biomarker of brain function biomarker in relation to treatment-emergent symptom worsening.
METHOD: Seventy-two major depressive disorder (MDD) subjects were treated with fluoxetine 20 mg (n = 13), venlafaxine 150 mg (n = 24), or placebo (n = 35) under double-blind conditions. Behavioral ratings determined whether each subject demonstrated worsening of depressed mood, anxiety, or SI during treatment. QEEG cordance data were analyzed to determine whether symptom worsening was associated with neurophysiological changes.
RESULTS: Antidepressant treatment-emergent SI (13.5%) was associated with a large transient decrease in midline-and-right-frontal (MRF) cordance 48 h after start of medication.
CONCLUSION: Hypothesis-generating results suggest a pattern of functional changes in midline and right frontal brain regions associated with antidepressant treatment-emergent SI in MDD.
© 2010 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20384600     DOI: 10.1111/j.1600-0447.2010.01560.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  7 in total

1.  Transcranial low-level infrared laser irradiation ameliorates depression induced by reserpine in rats.

Authors:  Haitham S Mohammed
Journal:  Lasers Med Sci       Date:  2016-07-20       Impact factor: 3.161

2.  Plant Natural Product Puerarin Ameliorates Depressive Behaviors and Chronic Pain in Mice with Spared Nerve Injury (SNI).

Authors:  Jia Zhao; Dan Luo; Zhaohui Liang; Lixing Lao; Jianhui Rong
Journal:  Mol Neurobiol       Date:  2016-03-24       Impact factor: 5.590

3.  Altered functional protein networks in the prefrontal cortex and amygdala of victims of suicide.

Authors:  Katalin Adrienna Kékesi; Gábor Juhász; Attila Simor; Péter Gulyássy; Eva Mónika Szegő; Eva Hunyadi-Gulyás; Zsuzsanna Darula; Katalin F Medzihradszky; Miklós Palkovits; Botond Penke; András Czurkó
Journal:  PLoS One       Date:  2012-12-06       Impact factor: 3.240

Review 4.  Intermediate phenotypes and biomarkers of treatment outcome in major depressive disorder.

Authors:  Andrew F Leuchter; Aimee M Hunter; David E Krantz; Ian A Cook
Journal:  Dialogues Clin Neurosci       Date:  2014-12       Impact factor: 5.986

Review 5.  Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential Analysis.

Authors:  Janus Christian Jakobsen; Kiran Kumar Katakam; Anne Schou; Signe Gade Hellmuth; Sandra Elkjær Stallknecht; Katja Leth-Møller; Maria Iversen; Marianne Bjørnø Banke; Iggiannguaq Juhl Petersen; Sarah Louise Klingenberg; Jesper Krogh; Sebastian Elgaard Ebert; Anne Timm; Jane Lindschou; Christian Gluud
Journal:  BMC Psychiatry       Date:  2017-02-08       Impact factor: 3.630

6.  Resting and TMS-EEG markers of treatment response in major depressive disorder: A systematic review.

Authors:  Rebecca Strafella; Robert Chen; Tarek K Rajji; Daniel M Blumberger; Daphne Voineskos
Journal:  Front Hum Neurosci       Date:  2022-08-04       Impact factor: 3.473

7.  Does suicidal desire moderate the association between frontal delta power and psychological pain?

Authors:  Esther L Meerwijk; Sandra J Weiss
Journal:  PeerJ       Date:  2016-01-04       Impact factor: 2.984

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.